Changes in microrna (mir) profile and effects of mir-320 in insulin-resistant 3t3-l1 adipocytes

Clinical and Experimental Pharmacology and Physiology

Volumn 36, Issue 9, 2009, Pages

  Ling, Hong Yan ^a,b,c   Ou, He Sheng ^b   Feng, Shui Dong ^d   Zhang, Xiao Ying ^b   Tuo, Qin Hui ^b   Chen, Lin Xi ^b   Zhu, Bing Yang ^b   Gao, Zhi Ping ^b   Tang, Cao Ke ^e   Yin, Wei Dong ^e   Zhang, Liang ^e,f   Liao, Duan Fang ^a,b,e  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Institute of Pharmacy and Pharmacology   (China)

^c School of Medicine

^d Dept ot Hlth Management and Policy   (Indonesia)

^e UNIVERSITY OF SOUTH CHINA   (China)

^f Palmer Center for Chiropractic Research   (United States)

Author keywords

3T3 L1 adipocytes; Expression profile; Insulin resistance; MicroRNA; MiR 320; Phosphatidylinositol 3 kinase

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; MICRORNA; MICRORNA 320; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P85; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOINFORMATICS; CELL CULTURE; CELL DIFFERENTIATION; CELL STRAIN 3T3; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; DOWN REGULATION; GENETIC TRANSFECTION; GLUCOSE TRANSPORT; INSULIN RESISTANCE; INSULIN SENSITIVITY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; CLASS IA PHOSPHATIDYLINOSITOL 3-KINASE; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; INSULIN; INSULIN RESISTANCE; MICE; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OLIGONUCLEOTIDES, ANTISENSE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION;

EID: 69949099167     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2009.05207.x     Document Type: Article

References (48)

1. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001 294 : 853 858.
2. Lee RC, Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science 2001 294 : 862 864.
3. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993 75 : 843 854.
4. Wightman B, Ha I, Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 1993 75 : 855 862.
5. Bartel DP. MicroRNAs. Genomics, biogenesis, mechanism, and function. Cell 2004 116 : 281 297.
6. Yekta S, Shih IH, Bartel DP. MicroRNA-directed cleavage of HOXB8 mRNA. Science 2004 304 : 594 596.
7. Lim LP, Lau NC, Garrett-Engele P et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005 433 : 769 773.
8. Roldo C, Missiaglia E, Hagan JP et al. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J. Clin. Oncol. 2006 24 : 4677 4684.
9. Zhao JJ, Hua YJ, Sun DG et al. Genome-wide microRNA profiling in human fetal nervous tissues by oligonucleotide microarray. Childs Nerv. Syst. 2006 22 : 1419 1425.
10. Ambros V. The functions of animal microRNAs. Nature 2004 43 : 350 355.
11. Wienholds E, Plasterk RH. MicroRNA function in animal development. FEBS Lett. 2005 579 : 5911 5922.
12. Cheng AM, Byrom MW, Shelton J, Ford LP. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 2005 33 : 1290 1297.
13. Peizhang X, Vernooy SY, Hay BA. The Drosophila microRNA mir-14 suppresses cell death and is required for normal fat metabolism. Curr. Biol. 2003 13 : 790 795.
14. Teleman AA, Cohen SM. Drosophila lacking microRNA miR-278 are defective in energy homeostasis. Genes Dev. 2006 20 : 417 422.
15. Gauthier BR, Wollheim CB. MicroRNAs: 'ribo-regulators' of glucose homeostasis. Nat. Med. 2006 12 : 36 8.
16. Poy MN, Spranger M, Stoffel M. MicroRNAs and the regulation of glucose and lipid metabolism. Diabetes Obes. Metab. 2007 9 : 67 73.
17. Esau C, Davis S, Murray SF et al. MiR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell. Metab. 2006 3 : 87 98.
18. Baroukh N, Ravier MA, Loder MK et al. MicroRNA-124a regulates Foxa2 expression and intracellular signaling in pancreatic β-cell lines. J. Biol. Chem. 2007 282 : 19 575 88.
19. Poy MN, Eliasson L, Krutzfeldt J et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004 432 : 226 230.
20. Plaisance V, Abderrahmani A, Perret-Menoud V et al. MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells. J. Biol. Chem. 2006 281 : 26 932 42.
21. Das SK, Elbein SC. The genetic basis of Type 2 diabetes. Cell. Sci. 2006 2 : 100 131.
22. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001 414 : 782 787.
23. Chakraborty C. Biochemical and molecular basis of insulin resistance. Curr. Protein Pept. Sci. 2006 7 : 113 121.
24. Guilherme A, Virbasius JV, Puri V, Czech MP. Adipocyte dysfunctions linking obesity to insulin resistance and Type 2 diabetes. Nat. Rev. Mol. Cell. Biol. 2008 9 : 367 377.
25. Hauner H. The new concept of adipose tissue function. Physiol. Behav. 2004 83 : 653 658.
26. Nugent C, Prins JB, Whitehead JP et al. Potentiation of glucose uptake in 3T3-L1 adipocytes by PPAR gamma agonists is maintained in cells expressing a PPAR gamma dominant-negative mutant: Evidence for selectivity in the downstream responses to PPAR gamma activation. Mol. Endocrinol. 2001 15 : 1729 1738.
27. Sahai A, Patel MS, Zavosh AS, Tannen RL. Chronic hypoxia impairs the differentiation of 3T3-L1 fibroblast in culture: Role of sustained protein kinase C activation. J. Cell. Physiol. 1994 160 : 107 112.
28. -ΔΔCT method. Methods 2001 25 : 402 408.
29. Ross SA, Chen X, Hope HR et al. Development and comparison of two 3T3-L1 adipocyte models of insulin resistance: Increased glucose flux vs glucosamine treatment. Biochem. Biophys. Res. Commun. 2000 273 : 1033 1041.
30. Thomson MJ, Williams MG, Frost SC. Development of insulin resistance in 3T3-L1 adipocytes. J. Biol. Chem. 1997 272 : 7759 7764.
31. Lewis BP, Shih IH, Jones-Rhoades MW et al. Prediction of mammalian microRNA targets. Cell 2003 115 : 787 798.
32. Enright AJ, John B, Gaul U et al. MicroRNA targets in Drosophila. Genome Biol. 2003 5 : R1.
33. Griffiths-Jones S. The microRNA registry. Nucleic Acids Res. 2004 32 : D109 11.
34. Yang YB, Yang YX, Tang YL et al. Probucol mediates vascular remodeling after percutaneous transluminal angioplasty via down-regulating ERK1/2 signal transduction pathway. Eur. J. Pharmacol. 2007 570 : 125 134.
35. Farmer SR. Transcriptional control of adipocyte formation. Cell Metab. 2006 4 : 263 273.
36. Gregoire FM, Smas CM, Sul HS. Understanding adipocyte differentiation. Physiol. Rev. 1998 78 : 783 809.
37. Van DE, Govers R, James DE. Akt activation is required at a late stage of insulin-induced GLUT4 translocation to the plasma membrane. Mol. Endocrinol. 2005 19 : 1067 1077.
38. Kotani K, Carozzi AJ, Sakaue H et al. Requirement for phosphoinositide 3-kinase in insulin-stimulated GLUT4 translocation in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 1995 209 : 343 348.
39. Krutzfeldt J, Rajewsky N, Braich R et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005 438 : 685 689.
40. Esau C, Kang X, Peralta E et al. MicroRNA-143 regulates adipocyte differentiation. J. Biol. Chem. 2004 279 : 52361 52365.
41. Kahn CR. Insulin resistance: A common feature of diabetes mellitus. N. Engl. J. Med. 1986 315 : 252 254.
42. Wang XH, Qian EZ, Zhang W et al. MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats. Clin. Exp. Pharmacol. Physiol. 2009 36 : 181 188.
43. Wei YZ, Sowers JR, Clark SE et al. Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-κB activation via NADPH oxidase. Am. J. Physiol. Endocrinol. Metab. 2008 294 : E345 51.
44. Berger J, Biswas C, Vicario PP et al. Decreased expression of the insulin-responsive glucose transporter in diabetes and fasting. Nature 1989 340 : 70 2.
45. Taniguchi CM, Aleman JO, Ueki K et al. The p85α regulatory subunit of phosphoinositide 3-kinase potentiates c-Jun N-terminal kinase-mediated insulin resistance. Mol. Cell. Biol. 2007 27 : 2830 2840.
46. Taniguchi CM, Tran TT, Kondo T et al. Phosphoinositide 3-kinase regulatory subunit p85a suppresses insulin action via positive regulation of PTEN. Proc. Natl Acad. Sci. USA 2006 103 : 12 093 7.
47. Gross B, Staels B. PPAR agonists. Multimodal drugs for the treatment of Type-2 diabetes. Best Pract. Res. Clin. Endocrinol. Metab. 2007 21 : 687 710.
48. Itoh H, Doi K, Tanaka T et al. Hypertension and insulin resistance: Role of peroxisome proliferator-activated receptor γ. Clin. Exp. Pharmacol. Physiol. 1999 26 : 558 560.